A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis.
A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis.
Proc (Bayl Univ Med Cent). 2019 Apr;32(2):231-234
Authors: Espinosa MC, Ding B, Choi K, Cohen DN, Marcelli M, Ifoeze OW
Abstract
Frequently used in the management of hypertension and heart failure, hydralazine is associated with the development of adverse rheumatologic side effects. The authors highlight a unique case of drug-induced lupus and drug-induced anti-neutrophil cytoplasmic antibody (ANCA) vasculitis from hydralazine use in a 50-year-old man with sarcoidosis and hypertension.
PMID: 31191136 [PubMed]
Source: Baylor University Medical Center Proceedings - Category: Universities & Medical Training Authors: Espinosa MC, Ding B, Choi K, Cohen DN, Marcelli M, Ifoeze OW Tags: Proc (Bayl Univ Med Cent) Source Type: research
More News: Cardiology | Heart | Heart Failure | Hydralazine | Hypertension | Lupus | Rheumatology | Sarcoidosis | Universities & Medical Training | Vasculitis